Advertisement

2 Great Reasons to Buy This Cancer Treatment Stock Now

2 Great Reasons to Buy This Cancer Treatment Stock Now

The S&P 500 is chugging along nicely with a 14% gain year to date, but stocks like Apple (NASDAQ: AAPL) and Amazon (NASDAQ: AMZN) -- both of which came out with mind-blowing revenue and earnings numbers earlier in the year -- have somehow failed to climb. Clovis Oncology (NASDAQ: CLVS) may fit that bill. As a biotech aimed at improving and saving lives, Clovis is focused on advancing the fight against cancer with treatments for patients across the U.S., Europe, and internationally.